Glycogen Storage Disease Type III diagnosis and management guidelinesPriya S. Kishnani, Michael S. Watson, Stephanie Austin et al.|Genetics in Medicine|2010Cited by 305
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseMarc Nicolino, Priya S. Kishnani, Georgianne L. Arnold et al.|Genetics in Medicine|2009Cited by 292
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental DelayKelly Schoch, Sureni V. Mullegama, Linyan Meng et al.|The American Journal of Human Genetics|2017Cited by 51